Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

TsingKe / 擎科生物

Request full access

Beijing gene-synthesis + CRISPR tools platform (oligo/gene synth, sgRNA)

ChinaFounded 2017Biotech & Life Sciences

About TsingKe / 擎科生物

Beijing gene-synthesis and CRISPR tools platform TsingKe (擎科生物 / 北京擎科生物科技) provides oligo and gene synthesis, Sanger and NGS services, life-science reagents and instruments, and sgRNA / HDR gene-editing synthesis for academia and biopharma from Beijing Economic-Technological Development Area. Founded 2017, the company runs an integrated synthetic-biology gene factory spanning genomics products, research equipment and biomanufacturing CRO/CDMO with roughly 1,250 to 1,400 staff at IPO prospectus scale. Mid-size China gene-editing / CRISPR tools leftover beyond RiboBio FIX and Ubigene soft-skip.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
China
Employees
9
Open positions
None listed
Dealroom signal
33.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOOther financing Jan 2026 $0 — Undisclosed ↗
SERIES BOther financing Dec 2022 $55M $220M Jinyu Maowu Investment · Capitallink ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

TsingKe / 擎科生物 website traffic

Latest recorded traffic for TsingKe / 擎科生物 is 1.1K monthly website visits, up 189.5% over the last three months. TsingKe / 擎科生物's team declined 10% over the past year.

Latest monthly visits1.1K 3-month web change+189.5% 1-year team growth-10%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

TsingKe / 擎科生物 in its local ecosystem

Live from Dealroom

The TsingKe / 擎科生物 office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Shengyu Investment
  • SB China Capital
  • Yueyin Venture Capital
  • Jinyu Maowu Investment
  • Capitallink

Other known investors1 additional known investor

  • Cowin Capital
Employees 9 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about TsingKe / 擎科生物 on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TsingKe / 擎科生物’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.